BF Biosciences Limited (BFBL), jo ke Ferozsons Laboratories Limited ki ek subsidiary hai, ne abhi haal hi mein Lucky Core Industries Limited (LCI) ke sath ek ahem contract manufacturing aur supply agreement final kiya hai. Yeh muahida do important products, “Esopase IV 40 mg” aur “Etipro IV 40 mg” ke liye hai, jo dawaaiyon ke field mein badi significance rakhti hain.
Agreement ke tehat, BF Biosciences in dono products ki manufacturing karega, aur inka supply bhi BFBL ke zariye hi hoga. Is se BFBL apne operational capabilities ko mazeed strong karega aur apne manufacturing setup ko aur modernize karne ka mouqa milega. Dusri taraf, Lucky Core Industries, jo pharmaceuticals aur chemicals ke maidan mein apna maqam rakhti hai, is partnership ke zariye apni product range mein mazeed izafa karegi.
Yeh partnership dono companies ke liye faidemand hogi, jahan ek taraf Lucky Core Industries apni market positioning ko aur bhi stable karegi, wahin BF Biosciences apne expertise aur market reach ko badhawa dega. Dono companies ne yeh muahida karte waqt apne mutual benefits aur growth potential ko madde nazar rakha hai, jo ke aane wale dinon mein market pe positive asar daalega.
